RegTrain – PharmTrain

Regulatory Training and Advice in the Field of Pharmaceuticals

The RegTrain-PharmTrain team in front of the Federal Institute for Drugs and Medical Device (BfArM) (Source: BfArM)

Short Description

The recurrent Ebola epidemics of recent years, as well as other infectious diseases widespread in Africa such as HIV, tuberculosis or malaria, show that effective and safe medicines for the prevention and treatment of these infectious diseases are not, or not sufficiently, available. Under the umbrella name “RegTrain” the BfArM (PharmTrain) together with the Paul Ehrlich Institute (VaccTrain) supports the development of necessary scientific and regulatory capacities in African partner countries. In cooperation with the World Health Organization (WHO) and the multinational New Partnership for Africa’s Development agency (AUDA-NEPAD), the following objectives are being pursued:

  1. Analysis and evaluation of the current situation in the partner countries and preparation of individual development plans for building regulatory structures and scientific capacities.
  2. Establishing sustainable training structures according to the Train-the-Trainer principle. Particularly suitable colleagues from the African partner authorities are trained at the BfArM with follow-up support after returning to their home authority, so that they are able to pass on their knowledge and skills to their colleagues in Africa. In addition to North-South cooperation, this also promotes South-South cooperation.
  3. The overall objective is to contribute to the establishment of harmonised regulatory structures as well as scientific and regulatory capacities in order to promote cooperation between the authorities of different countries, to strengthen the regulatory system across countries and to improve drug safety.

Video: The PharmTrain project – Its first year

From 2023, the RegTrain-PharmTrain project will continue as a follow-up project under the name PharmTrain2.

In Cooperation with

  • Food and Drug Administration (FDA), Ghana
  • Liberia Medicines and Health Products Regulatory Authority (LMHRA), Liberia
  • Pharmacy Board Sierra Leone (PBSL), Sierra Leone
  • Medicines Control Agency (MCA), The Gambia
  • Medicines Control Authority of Zimbabwe (MCAZ), Zimbabwe
  • Paul-Ehrlich-Institut (PEI), Germany
  • World Health Organization (WHO), Switzerland
  • New Partnership for Africa’s Development Agency (AUDA-NEPAD), South Africa

Publications and Conference Presentations

Last update: December 2022



01.01.2019 - 31.12.2022


ca. 1,600,000 EUR

Partner Countries

  • The Gambia
  • Ghana
  • Liberia
  • Sierra Leone
  • Zimbabwe